Patents by Inventor Christoph Huschka

Christoph Huschka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hyaluronate lyase used for promoting penetration in topical agents
    Patent number: 6719986
    Abstract: The invention relates to an agent for treating skin diseases and/or functional disorders of the skin on the basis of different medicaments and/or auxiliary substances through promotion of penetration from topical formulations into the skin. According to the invention, the agent is composed of a hyaluronate lyase produced by microbial means and a medicament, preferably a hydrophilic medicament and/or auxiliary substances in different galenic formulations including colloidal carrier systems. The areas of application for the invention in human and veterinary medicament relate to the treatment, prophylaxis and/or metaphylaxis of skin diseases, functional disorders of the skin, the processes of skin ageing and dry skin conditions.
    Type: Grant
    Filed: September 5, 2001
    Date of Patent: April 13, 2004
    Assignee: esparma GmbH
    Inventors: Wolfgang Wohlrab, Reinhard Neubert, Christoph Huschka, Peter-Jürgen Müller, Jörg-Herman Ozegowski, Dieter Koegst, Gerhard Fries
  • Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
    Patent number: 6689349
    Abstract: The invention relates to an agent for the treatment, prophylaxis and metaphylaxis of functional and structural disorders of the skin caused by external factors. The agent contains a hyaluronic acid partially digested with a microbiological hyaluronate lyase. The hyaluronic acid fragment mixture is incorporated in different galenic formulations to which other hydrophilic and/or lipophilic active substances and/or auxiliary substances can be added. Fields of application of the invention in human and veterinary medicine relate to the treatment and/or the prophylaxis of skin damage caused by environmental factors including UV, dry skin conditions and skin ageing.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: February 10, 2004
    Assignee: esparma GmbH
    Inventors: Wolfgang Wohlrab, Reinhard Neubert, Christoph Huschka, Peter-Jürgen Müller, Jörg-Herman Ozegowski, Dieter Koegst, Gerhard Fries
  • Galenic formulation containing biotin
    Patent number: 6660251
    Abstract: The invention relates to galenic formulations which contain a) one or more compounds selected from biotin, its physiologically compatible salts, biotin esters and the steroisomeric forms of these compounds; and b) one or more compounds selected from urea and urea derivatives. The above formulations are suitable for use as topically administered formulations for the cosmetic and/or medical treatment of the skin, hair and/or nails.
    Type: Grant
    Filed: July 27, 2001
    Date of Patent: December 9, 2003
    Assignee: Merck Patent GmbH
    Inventors: Joachim Bünger, Hansjürgen Driller, Wolfgang Wohlrab, Lothar Motitschke, Christoph Huschka, Reinhard Neubert
  • Pharmaceutical preparation containing dithranol
    Patent number: 6413950
    Abstract: The invention relates to a pharmaceutical preparation in a make-up which is suited for external application and which contains a dithranol derivative as an active ingredient.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: July 2, 2002
    Assignee: esparma GmbH
    Inventors: Jürgen Schneider, Wolfgang Wohlrab, Reinhard Neubert, Christoph Huschka, Dieter Koegst, Gerhard Fries